Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) causes a wide spectrum of
clinical manifestations, with progression to multiorgan failure in the most severe cases …

Altered immune cell phenotype and chronic inflammation are key features shared by various
chronic diseases. Evidence from nutritional interventions aimed at alleviating inflammation …

The coronavirus disease 2019 (COVID19) pandemic continues to represent a substantial
public health concern. It can rapidly progress to severe disease, with poor prognosis and a …

The lung is the primary site of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2)-induced immunopathology whereby the virus enters the host cells by binding to …

Coronavirus disease 2019 (COVID-19) is a transmitted respiratory disease caused by the
infection of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is causing an ongoing
pandemic of coronavirus disease 2019 (Covid‐19). Effective therapies are required for the …

This study aims to estimate the prevalence and longevity of detectable SARS-CoV-2
antibodies and T and B memory cells after recovery. In addition, the prevalence of COVID-19 …

Infection with the SARS-CoV2 virus can vary from asymptomatic, or flu-like with moderate
disease, up to critically severe. Severe disease, termed COVID-19, involves acute …

Abnormal immunological indicators associated with disease severity and mortality in
patients with COVID-19 have been reported in several observational studies. However …

The implication of the ABO blood group in COVID-19 disease was formulated early, at the
beginning of the COVID-19 pandemic more than 2 years ago. It has now been established …